Cudrania cochinchinensis attenuates amyloid β protein-mediated microglial activation and promotes glia-related clearance of amyloid β protein

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Wang, Chung Jen ^a   Chen, Chien Chih ^b   Tsay, Huey Jen ^c   Chiang, Feng Yi ^c   Wu, Mine Fong ^c   Shiao, Young Ji ^c,d  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Alzheimer's disease; Amyloid ; Cudrania cochinchinensis; Microglia; Mixed glial culture; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN; CUDRANIA COCHINCHINENSIS EXTRACT; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLANT EXTRACT; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL VIABILITY; CUDRANIA COCHINCHINENSIS; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MEDICINAL PLANT; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ALZHEIMER DISEASE; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; MORACEAE; RAT; SPRAGUE DAWLEY RAT; DRUG EFFECT;

MACLURA COCHINCHINENSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; INTERFERON-GAMMA; MICROGLIA; MORACEAE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDE FRAGMENTS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84880868546     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-55     Document Type: Article

References (32)

1. Antimicrobial activity of hydrophobic xanthones from Cudrania cochinchinensis against Bacillus subtilis and methicillin-resistant Staphylococcus aureus. Fukai T, Oku Y, Hou AJ, Yonekawa M, Terada S, Chem Biodivers 2004 1 1385 1390 10.1002/cbdv.200490101 17191916
2. 1,3,5-Trihydroxy-4- prenylxanthone represses lipopolysaccharide-induced iNOS expression via impeding posttranslational modification of IRAK-1. Chiou WF, Chen CC, Lin IH, Chiu JH, Chen YJ, Biochem Pharmacol 2011 81 752 760 10.1016/j.bcp.2010.12.022 21232528
3. Microglial progenitors with a high proliferative potential in the embryonic and adult mouse brain. Alliot F, Lecain E, Grima B, Pessac B, Proc Natl Acad Sci USA 1991 88 1541 1545 10.1073/pnas.88.4.1541 1996355 (Pubitemid 21916261)
4. Microglial cell origin and phenotypes in health and disease. Saijo K, Glass CK, Nat Rev Immunol 2011 11 775 787 10.1038/nri3086 22025055
5. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Nimmerjahn A, Kirchhoff F, Helmchen F, Science 2005 308 1314 1318 10.1126/science.1110647 15831717 (Pubitemid 40746128)
6. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. Jimenez S, Baglietto-Vargas D, Caballero C, Moreno-Gonzalez I, Torres M, Sanchez-Varo R, Ruano D, Vizuete M, Gutierrez A, Vitorica J, J Neurosci 2008 28 11650 11661 10.1523/JNEUROSCI.3024-08.2008 18987201
7. Imaging microglial activation during neuroinflammation and Alzheimer's disease. Venneti S, Wiley CA, Kofler J, J Neuroimmune Pharmacol 2009 4 227 243 10.1007/s11481-008-9142-2 19052878
8. Marcrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity. Li M, Pisalyaput K, Galvan M, Tenner AJ, J Neurochem 2004 91 623 633 10.1111/j.1471-4159.2004.02765.x 15485493 (Pubitemid 39431157)
9. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. Farfara D, Lifshitz V, Frenkel D, J Cell Mol Med 2008 12 762 780 10.1111/j.1582-4934.2008.00314.x 18363841 (Pubitemid 351718063)
10. Microglia and Alzheimer's disease pathogenesis. Streit WJ, J Neurosci Res 2004 77 1 8 10.1002/jnr.20093 15197750 (Pubitemid 38850050)
11. Alzheimer's disease. Querfurth HW, LaFerla FM, N Engl J Med 2010 362 329 344 10.1056/NEJMra0909142 20107219
12. Neurotrophin secretion from cultured microglia. Nakajima K, Honda S, Tohyama Y, Imai Y, Kohsaka S, Kurihara T, J Neurosci Res 2001 5 322 331 (Pubitemid 32727034)
13. The role of microglia in amyloid clearance from the AD brain. Lee CY, Landreth GE, J Neural Transm 2010 117 949 960 10.1007/s00702-010-0433-4 20552234
14. Mechanism mediating oligomeric Abeta clearance by naïve primary microglia. Yang CN, Shiao YJ, Shie FS, Guo BS, Chen PH, Cho CY, Chen Y, Huang JFL, Tsay HJ, Neurobiol Dis 2011 42 221 230 10.1016/j.nbd.2011.01.005 21220023
15. Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD. Tundo G, Ciaccio C, Sbardella D, Boraso M, Viviani B, Coletta M, Marini S, PLoS One 2012 7 34376 10.1371/journal.pone.0034376 22509294
16. Characterization of amoeboid microglia isolated from developing mammalian brain. Giulian D, Baker TJ, J Neurosci 1986 6 2163 2178 3018187 (Pubitemid 16043659)
17. Self-assembly of Abeta (1-42) into globular neurotoxins. Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT, Jones BW, Fernandez SJ, Lacor PN, Horowitz PC, Finch E, Krafft GA, Klein WL, Biochemistry 2003 42 12749 12760 10.1021/bi030029q 14596589 (Pubitemid 37385806)
18. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ, J Biol Chem 2002 277 32046 32053 10.1074/jbc.M201750200 12058030 (Pubitemid 34969015)
19. Enlargement of Abeta aggregates through chemokinedependent microglial clustering. Huang WC, Yen FC, Shiao YJ, Shie FS, Chan JL, Yang CN, Sung YJ, Huang FL, Tsay HJ, Neurosci Res 2009 63 280 287 10.1016/j.neures.2009.01.001 19367788
20. Vitamine E induces ramification and down regulation of adhesion molecules in cultured microglial cells. Heppner FL, Roth K, Nitsch R, Hailer NP, Glia 1998 22 180 188 10.1002/(SICI)1098-1136(199802)22:2<180::AID-GLIA9>3.0. CO;2-B 9537838 (Pubitemid 28084390)
21. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM, J Neurosci 2001 21 8370 8377 11606625 (Pubitemid 33051435)
22. Sinomenine inhibits microglial activation by Aβ and confers neuroprotection. Shukla SM, Sharma SK, J Neuroinflamm 2011 8 117 10.1186/1742-2094-8-117
23. Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. Maezawa I, Zimin PI, Wulff H, Jin LW, J Biol Chem 2011 286 3693 3706 10.1074/jbc.M110.135244 20971854
24. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. Sondag CM, Dhawan G, Combs CK, J Neuroinflamm 2009 6 1 10.1186/1742-2094-6-1
25. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-β Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P, J Neuroimmunol 2009 210 3 12 10.1016/j.jneuroim.2009.02.003 19269040
26. Identification of Cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach. Gan L, Ye S, Chu A, Anton K, Yi S, Vincent VA, von Schack D, Chin D, Murray J, Lohr S, Patthy L, Gonzalez-Zulueta M, Nikolich K, Urfer R, J Biol Chem 2004 279 5565 5572 14612454 (Pubitemid 38220582)
27. Synergistic amplification of β-amyloid- and interferon-γ- induced microglial neurotoxic response by the senile plaque component chromogranin A. Twig G, Graf SA, Messerli MA, Smith PJS, Yoo SH, Shirihai OS, Am J Physiol Cell Physiol 2005 288 169 175
28. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. Mandrekar S, Jiang Q, Lee CYD, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE, J Neurosci 2009 29 4252 4262 10.1523/JNEUROSCI.5572- 08.2009 19339619
29. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ, J Biol Chem 1998 273 32730 32738 10.1074/jbc.273.49.32730 9830016 (Pubitemid 28557658)
30. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. Dirscherl K, Karlstetter M, Ebert S, Kraus D, Hlawatsch J, Walczak Y, Moehle C, Fuchshofer R, Langmann V, J Neuroinflamm 2010 7 3 10.1186/1742-2094-7-3
31. Transforming growth factor β's 1, 2 and 3 inhibit proliferation of ramified microglia on an astrocyte monolayer. Jones LL, Kreutzberg GW, Raivich G, Brain Res 1998 795 301 306 10.1016/S0006-8993(98)00325-4 9622658 (Pubitemid 28337844)
32. Microglia Lacking E Prostanoid Receptor Subtype 2 Have Enhanced Aβ Phagocytosis yet Lack Aβ-Activated Neurotoxicity. Shie FS, Breyer RM, Montine TJ, Am J Pathol 2005 166 1163 1172 10.1016/S0002-9440(10)62336-X 15793296 (Pubitemid 40524440)